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       INTRODUCTION 
  Hyponatremia is observed in the majority of adult and pedi-
atric patients with severe malaria.  1,2   A number of underlying 
mechanisms have been proposed, including the administra-
tion of hypotonic fluids, the syndrome of inappropriate anti-
diuretic hormone secretion (SIADH),  3–5   cerebral salt wasting 
(CSW),  6   losses through sweat and the gastrointestinal tract,  7  
renal losses,  8   and the “sick cell syndrome.”  9   There is, however, 
no consensus as to their relative contributions.  6,10   An  under-
standing of the pathophysiology is of major clinical importance 
because it might direct management strategies. In a patient 
with SIADH, for example, fluid restriction is the cornerstone 
of treatment.  11   By contrast, treatment of CSW requires large 
volumes of replacement fluid.  12  
  The importance of correcting the hyponatremia that com-
plicates severe malaria is debated. Some authors, noting that 
hyponatremia is associated with adverse outcomes in other 
clinical situations,  13  have suggested that it should be specifically 
and aggressively treated.  6   Others have argued that it is a physi-
ological response to hypovolemia requiring no specific ther-
apy beyond rehydration,  2   although the extent of hypovolemia 
in patients with severe malaria remains controversial.  9,14  
  In this study, we assessed the pathogenesis and prognosis 
of malaria-associated hyponatremia, using prospectively col-
lected data and plasma samples from two intervention studies 
in adult patients with severe falciparum malaria. 
   MATERIALS AND  METHODS 
  Patients.    Patients enrolled in clinical trials conducted at 
Chittagong Medical College Hospital (CMCH), Bangladesh, 
between 2003 and 2007, were included in this study. CMCH 
is a 1,000-bed tertiary referral hospital in the country’s sec-
ond largest city. There is no malaria transmission in the city 
of Chittagong, but CMCH serves a wide area including the 
Chittagong Hill Tracks, where malaria is unstable with sea-
sonal transmission. Informed consent was obtained from the 
families of all patients enrolled in the trials, which had been 
approved by the Ethics Committee of the Ministry of Health, 
Bangladesh, and OXTREC, the Ethical Committee for stud-
ies in tropical countries of Oxford University, UK. Patients 
from 2003 to 2005 were enrolled in a trial examining the util-
ity of   N  -acetylcysteine as adjuvant therapy in severe malaria 
(unpublished data). In 2006 and 2007, the patients were from 
a trial examining the efficacy of levamisole as adjuvant ther-
apy in severe malaria (study ongoing). All patients had to sat-
isfy pre-specified criteria for severe malaria  15   and have asexual 
forms of   Plasmodium falciparum   on a peripheral blood film. 
   Clinical  procedures.     Baseline venous blood was collected at 
study entry. Urine was collected, where possible, by indwell-
ing catheter. Thick and thin film microscopy was performed 
immediately to confirm eligibility, and basic laboratory 
results (plasma sodium, plasma potassium, blood urea nitro-
gen, blood glucose, plasma bicarbonate, plasma pH, hemoglo-
bin, and hematocrit) were available within minutes through 
the use of a portable hand-held point-of-care analyzer (iStat 
with EC8 + cartridges; Abbott Laboratories, Abbott Park, IL). 
Additional plasma was stored in liquid nitrogen until assayed 
for anti-diuretic hormone (ADH) and brain natriuretic pep-
tide (BNP). Urine specimens were frozen until subsequent 
analysis of electrolyte concentrations. Patients were managed 
according to published WHO guidelines,  7,16  including resuscita-
tion with normal saline titrated against the clinical assessment 
of dehydration. 
  ADH concentrations were estimated using a radioimmu-
noassay of extracted plasma (Buhlmann Laboratories, Basel, 
Switzerland). N-terminal fragment BNP (NT-pro BNP) was 
measured using reagents supplied by Roche Diagnostics on 
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an Elecsys 2010 analyzer (Roche Diagnostics, Castle Hill, 
Australia). The normal ranges were 0.1–7.0 pmol/L for ADH 
and < 97 ng/L for NT-pro BNP. 
   Data  analysis.     The Cockcroft and Gault formula  17   was used 
to estimate creatinine clearance as a measure of glomerular fil-
tration.  18   Plasma osmolarity was calculated using the formula 
2 × (plasma Na) + (plasma blood urea nitrogen) + plasma 
glucose (all in SI units; reference range, 275–295 mosm/kg). 
Fractional excretion of sodium (FENa) was calculated as (uri-
nary sodium × plasma creatinine)/(plasma sodium × urinary 
creatinine) × 100. 
  Patient data were de-identified, entered into a computer-
ized database (Microsoft Access; Microsoft Corp., Redmond, 
WA), and analyzed using a statistical software package (Stata 
9.0; StataCorp, College Station, TX). Unless otherwise indi-
cated, data are presented as mean and 95% confidence inter-
vals (CIs). Variables that were not normally distributed were 
analyzed using Spearman rho and Wilcoxon signed rank test. 
Fisher exact and c  2   tests were used to assess dichotomous vari-
ables. Logistic regression was used to identify independent 
predictors of outcome. 
    RESULTS 
  Baseline  characteristics.    One hundred eighty-one patients 
(median age, 35 years; range, 13–70 years; 79.5% male) were 
recruited to studies at CMCH over 5 years. Of the 181 patients, 
171 (94.5%) had sufficient data for these analyses. Of the 10 
patients not included, 5 did not have an iStat specimen col-
lected, 4 had insufficient admission clinical data, and 1 had an 
invalid iStat result. The characteristics of the included patients 
are  recorded  in  Table  1            . 
      Prevalence and correlates of hyponatremia.     The mean 
admission plasma sodium was 133 mmol/L (range, 117–155 
mmol/L); 57% were hyponatremic (plasma sodium <  135 
mmol/L) and 30% had a plasma sodium < 130 mmol/L. Fifty-
four (35%) patients received intravenous fluid (usually < 1 L) 
before enrolment, and in 17 cases, it was unclear whether 
fluid had been administered. If these 71 patients are excluded, 
the mean (95% CI) plasma sodium [133 mmol/L (131–134 
mmol/L)] and the proportion of patients with a plasma sodium 
< 135 and 130 mmol/L (61% and 31%, respectively) remained 
similar. For the purposes of this study, data from these patients 
were not analyzed separately. 
  Compared with patients with a normal plasma sodium (135–
145 mmol/L), those with hyponatremia had a higher Glasgow 
Coma Scores (GCSs), had greater parasite densities, and were 
less  acidotic  ( Table  2 ).              There  was  no  significant  difference  in 
the admission creatinine clearance between the two groups. 
When the data were pooled, there was an inverse relationship 
between GCS and the admission plasma sodium (  N   = 171, 
  r  s   = −0.36,   P   < 0.0001;   Figure 1  ).   
  There was no relationship between the plasma sodium and 
the urinary sodium measured either as the urinary sodium 
concentration (  r  s   = 0.1,   P   = 0.17) or FENa (  r  s   = 0.09,   P   = 
0.26). Sixty-seven patients had their plasma osmolarity mea-
sured and thus could have an osmolar gap calculated. In these 
patients, there was no relationship between the plasma sodium 
and the measured osmolar gap (  r  s   = −0.13,   P   = 0.29). 
   Plasma  ADH,  BNP,  and  hyponatremia.    Plasma  ADH  was 
measured using the admission blood sample from 30 patients 
(all those from 2006). Patients who were hyponatremic ( N  = 24) 
had a median (range) ADH of 6.1 (2.3–85.3) pmol/L com-
pared with 32.7 (3.0–56.4) pmol/L in those with a normal 
plasma sodium level (  N   = 6;   P   = 0.19). There was a significant 
relationship between plasma ADH levels and the measured 
plasma osmolarity (  r  s   = 0.39,   N   = 30,   P   = 0.03). Plasma ADH 
was detected in all eight patients with a calculated osmolarity 
of < 280 mosm/kg (range, 2.3–40.1 pmol/L). 
  Twenty patients from the 2006 cohort had plasma BNP 
measured. There was no relationship between BNP and 
plasma sodium (  r  s   = 0.13,   P   = 0.58). Hyponatremic patients 
(  N   = 17) had a median (range) BNP of 520 (19–8,899) pg/mL 
compared with 610 (374–869) pg/mL in patients with a normal 
plasma sodium (  N   = 3). There was no relationship between 
BNP and urinary sodium (  r  s   = 0.21,   P   = 0.38) or FENa (  r  s   = 
0.31,   P   = 0.19). 
   Plasma  sodium  and  outcome.     The mortality rate in the 
171 patients was 40.4%. The 102 patients who survived had a 
lower admission plasma sodium [132 (130–133) mmol/L] 
than the 69 fatal cases [134 (133–136) mmol/L;   P   = 0.01]. 
Significantly fewer patients who were hyponatremic on admis-
sion died than those with a normal plasma sodium (odds ratio 
[95% CI]; 0.44 [0.23–0.82],  P  = 0.01). In addition, fewer patients 
with hyponatremia developed pulmonary edema, although 
the  requirement  for  dialysis  was  similar  ( Table  2 ).               In  a  logistic 
regression model with death as the dependent variable and 
  Table 1   
Patient characteristics 
          All values are means (95% CI) and are on admission unless otherwise stated.       
  *    Glasgow  Coma  Score  < 11.    
  †     BUN on admission > 21.4 mmol/L (60 mg/dL).       
  ‡    Hematocrit  < 20  on  admission.    
  §     Blood glucose level < 2 mmol/L.       
  ¶     Systolic blood pressure < 80 mm of Hg and cool peripheries.   
Median age (years)        35 (30–35)
Male sex (%)   136/171 (79.5%)
Mean mean arterial pressure (mmHg)        81 (79–84)
Mean pulse rate (beats/min)        115 (109–121)
Mean respiratory rate (breaths/min)        32 (31–33)
Mean oxygen saturation (%)          95 (94–95)
Mean plasma glucose (mmol/L) 8.6 (7.7–9.5)
Median Glasgow Coma Score          8 (7–9)
Mean sodium (mmol/L)        133 (132–134)
Mean potassium (mmol/L)       4.38 (4.23–4.52)
Mean plasma urea (mmol/L) 19.0 (16.9–21.1)
Mean plasma creatinine (µmol/L)        167 (146–189)
Mean plasma bicarbonate (mmol/L)        16 (15.7–17.2)
Mean base excess −8.3 (−9.3 to −7.3)
Mean venous lactate (mmol/L)  5.8 (5.3–6.4)
Mean total bilirubin (µmol/L)        134 (110–158)
Mean direct bilirubin (µmol/L)        68 (52–84)
Median peripheral parasite count (%)       2.55 (1.9–3.4)
Mean hematocrit 29.7 (28.4–31.1)
Median plasma Anti-diuretic 
hormone (pmol/L)
      7.45 (5–22.6)
Median plasma brain natriuretic 
peptide (pg/mL)
      554  (391–1,678)
Mean fractional excretion of sodium       1.16 (0.93–1.4)
Mean calculated osmolality (mosm/L)        293 (290–297)
Mean urinary osmolality (mosm/L)        528 (500–557)
Coma on admission*     130/171 (76%)
Acute renal failure† 56/171 (32.7%)
D  eveloped Pulmonary edema
 during admission
21/169 (12%)
Severe anemia‡ 20/171 (11.7%)
Spontaneous bleeding 7/171 (4%)
Convulsions 26/161 (16%)
Hypoglycemia§ 5/171 (3%)
Shock¶ 9/170 (5.3%)
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hyponatremia and coma (GCS < 11) as independent vari-
ables, hyponatremia was not independently associated with 
outcome (OR, 0.54; 95% CI, 0.28–1.06;   P   = 0.07), but coma 
remained a strong associate (OR, 5.8; 95% CI, 2.1–15.9;   
P   = 0.001). 
  Twelve patients had sequential specimens available for 
analysis (all those patients who survived to discharge and had 
complete  specimen  collection  in  2006;   Table  4 ).              Two  patients 
received dialysis on the first day of admission, affecting the 
interpretation of the serial measurements, and so their data 
were removed from the analysis. Hyponatremia improved 
rapidly in the remaining 10 patients with rehydration with 
normal saline. The median plasma sodium in these patients 
was 127 mmol/L (range, 123–140 mmol/L) on admission and 
136 mmol/L (range, 128–149 mmol/L) at 24 hours (  P   = 0.01). 
Creatinine clearance and plasma osmolarity also normalized 
during treatment, whereas the urine sodium concentrations 
and FENa rose (data not shown). 
    DISCUSSION 
 This study confirmed that hyponatremia is common in adults 
with severe malaria. Although there are a number of potential 
causes,  7   our data suggest that the major causative factor was 
ADH released appropriately in response to the hypovolemia 
evident clinically in the majority of patients at presentation. 
A decreased effective circulating blood volume will overcome 
the inhibition of ADH secretion that results from decreased 
plasma osmolarity.  19   Indeed, plasma ADH was easily measur-
able in patients with a plasma osmolarity < 280 mosm/kg when 
there should no longer be a stimulus for ADH release.  20  
  Under these circumstances, a hypovolemic but conscious 
patient who continues to drink water (or another hypo-
tonic fluid) will develop a dilutional hyponatremia. Our data 
showed an inverse correlation between level of consciousness 
and plasma sodium. It is therefore unsurprising that hypona-
tremic patients as a group had a better outcome than those 
with a normal plasma sodium, because impaired conscious-
ness has repeatedly been shown to be a strong predictor of 
mortality in severe malaria (see Table 3).  21,22   The fact that the 
association between hyponatremia and survival was no lon-
ger significant when controlled for impaired consciousness 
supports our hypothesis. Our data do not suggest that there 
is an important role for the SIADH in the development of 
malaria-associated hyponatremia. After admission, patients 
were rehydrated with intravenous normal saline—rather 
than being fluid restricted—and hyponatremia resolved with 
other markers of hypovolemia including creatinine clearance, 
the urea:creatinine ratio, and the FENa. Although the exact 
amounts of administered fluid were not recorded, patients 
without pulmonary edema usually received between 2 and 5 L 
of normal saline in the first 24 hours. 
  Other proposed explanations for the hyponatremia associ-
ated with severe malaria also seem inconsistent with our data. 
  Table 2   
Comparison of hyponatremic patients and patients with a normal plasma sodium* 
 
Plasma Na < 135 
  (   N   = 98)
Na normal* 
(  N   = 70)   P   value
GCS 9 (8–10) 6 (6–7) 0.0002
Peripheral parasite count (%) 4 (2.7–5.6) 1.5 (1−2.1) 0.0008
Base excess −7 (−8 to −5) −10 (−11.1 to −5.9) 0.18
Plasma bicarbonate (mmol/L) 18.2 (16.7–19.3) 14.9 (13.9–17) 0.01
Creatinine clearance (mL/min/1.73 m  2  ) 62.1 (50.3–73.1) 50 (39–71) 0.18
Required dialysis 19/98 19.4% 15/70 21.4% 0.85
Pulmonary edema developed 6/97† 6.2% 14/69† 20.3% 0.008
Died 31/98 (31.6%) 36/70 (51.4%) 0.01
    All  values  are  medians  (range).  
  *   Normal  plasma  sodium  135–145  mmol/L.  
    †     In one patient in each group, it was not possible to determine whether pulmonary edema developed.   
   Figure 1  .  Plasma sodium versus Glasgow Coma Score on admis-
sion.    
  Table 3   
Comparison of patients with normal and impaired GCS 
 
GCS ³ 15 
(  N   = 18)
GCS < 15 
(  N   = 153)   P   value
Na (mmol/L) 127 (124–132) 134 (132–135) 0.006
Creatinine clearance 
(mL/min)
77.2 (47–101.6) 54 (45.3–64.6)* 0.06
Required dialysis 2/18 (11.1%) 32/153 (20.9%) 0.53
HCO  3   (mmol/L) 18.8 (17.1–20.1) 16 (14.5–17) 0.048
Base excess −5 (−7 to −3) −8 (−10 to −6) 0.054
Death 2/18 (11.1%) 67/153 (44.2%) 0.009
Osmolarity 
(mosm/kg)
275 (264–290) 293 (288–397) 0.002
Lactate (mmol/L) 3.5 (3–4.6) 4.9 (4.4–5.5) 0.01
Parasite count (%) 11.3 (5–14.6) 2.1 (1.6–3) 0.001
Clinical hydration† Mild Moderate 0.08
ADH† 3.85 (2.32–6.34) 11.1 (4.9–34.5) 0.02
    All  values  are  medians  (range).  
    *     Six did not have a plasma creatinine on admission.   
    †     Data only available for 30 patients in 2006.   144 HANSON AND OTHERS
The patients were hyponatremic on admission, mostly before 
any active rehydration, thus excluding an important contri-
bution from hypotonic intravenous fluid administration. The 
absence of an association with the urinary sodium concentra-
tion and FENa argues against renal salt handling being the 
primary explanation for hyponatremia. Indeed, there was no 
association between hyponatremia and renal impairment. 
The inverse association with the GCS suggests that CSW, 
an entity that is itself controversial,  23   is not responsible for 
hyponatremia. Sweat and gastrointestinal secretions are hypo-
tonic,  24,25   and thus if losses from these sources were significant, 
patients would be hypernatraemic and hyperosmolar. The 
“sick cell” syndrome proposes that, in severe illness, patients 
develop increased cell membrane permeability with leakage 
of intracellular solutes and an osmotic gradient that leads to 
the passage of water from the cell and a resultant dilutional 
hyponatremia. Some authors have proposed this as a mecha-
nism for hyponatremia in malaria,  9   but our data did not show a 
relationship between plasma sodium and osmolar gap. 
  Data supporting our conclusions come from studies in 
adults and children. Sitprija and others  26   examined the volume 
status and hemodynamic responses of a series of Thai adults 
with moderately severe malaria. These authors identified 
a group of patients with reduced mean arterial pressure and 
creatinine clearance who also had activation of the renin–
angiotensin system and sympathetic nervous system and 
release of ADH. These patients were relatively hypona-
tremic. The authors hypothesized that these findings could 
be explained by a reduced effective circulating volume sec-
ondary to systemic vasodilatation, which led, in turn, to ADH 
release and a dilutional hyponatremia. English and others,  2   in 
a study of African children with severe malaria, found a statis-
tically significant association between weight gain and plasma 
sodium. Hyponatremic patients gained a mean of 2.4% body 
weight compared with a mean of 4.3% in the normonatremic 
group, suggesting that the hyponatremic patients were less 
dehydrated as a result of water retained by appropriate rather 
than inappropriate ADH secretion. 
  A small study of imported malaria in the United Kingdom 
showed no relationship between plasma ADH concentrations 
and plasma sodium, but there were no data presented regard-
ing disease severity.  27   A small study performed on a German 
intensive care unit concluded that SIADH contributes to the 
pathogenesis of hyponatremia in severe malaria, because 
plasma ADH concentrations were higher than expected for 
the plasma sodium concentration.  3   However, despite the fact 
that invasive monitoring was available, data were not corrected 
for hypovolemia, a factor that needs to be excluded before 
SIADH can be diagnosed.  20   A study in Kenyan children with 
severe malaria  28   suggested that 67% of hyponatremic cases 
had evidence of SIADH, based on the presence of detect-
able ADH levels despite low plasma sodium concentrations. 
However, because the patients were dehydrated and gained 
weight with intravenous rehydration, hypovolemia as a drive 
for ADH secretion cannot be excluded. Serial plasma elec-
trolyte and ADH concentration data were collected but not 
reported. It would have been interesting to observe changes 
in plasma sodium and ADH with rehydration. Cases of true 
SIADH in patients with severe falciparum malaria have been 
reported  29   but are likely to be uncommon. 
  Our study had limitations. Simultaneous longitudinal mea-
surements of plasma and urine biochemistry, ADH concen-
trations, and more invasive measurements of volume status, 
showing a simultaneous fall in ADH and rise in plasma sodium 
with rehydration, would have strengthened our observations. 
Our study was performed in a resource-poor, tropical setting 
where patients tend to present late, having had very little health 
care before admission. It examined only adult patients. The 
generalizability of our findings to other populations, especially 
those in non-tropical settings and children, may be limited. 
  In conclusion, this study showed that hyponatremia is a 
common feature in adults presenting with severe malaria but 
is not associated with increased mortality. Hypovolemia, and 
not SIADH, is the likely major pathophysiological mechanism, 
and simple rehydration with normal saline restores the plasma 
sodium to the normal range in the majority of cases. 
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  Table 4   
Plasma and urine biochemistry in patients with sequentially collected specimens 
  Admission 24 hours Discharge
Plasma sodium (mmol/L) 127 (123–140) 136 (128–149)* 137 (119–148)
Creatinine clearance (mL/min) 49 (21–129) 75 (25–115) 84 (40–135)*
Plasma osmolarity (mosm/kg) 308 (261–329) 305 (278–317) 287 (254–316)
Calc. osmolarity (mosm/kg) 298 (259–313) 298 (259–313) 282 (245–310)
Blood urea nitrogen (mmol/L) 15.2 (4.3–52) 9.8 (3.2–27.9)* 4.8 (2.9–12.1)†
UCR‡ 28.3 (15–58) 23.9 (10–41) 15 (8–31)†
Osmolar gap 9 (2.5–17.5) 5.1 (−7 to 29) 5 (0–22)
Urine osmolarity (mosm/kg) 573 (135–826) 585 (240–939) 432 (246–986)
Urinary sodium (mmol/L) 31.5 (10–66) 75.5 (9–143) 108 (32–241)†
Plasma potassium (mmol/L) 4.6 (3.3–5.3) 3.9 (3.4–5.5) 4 (2.4–4.6)*
Fractional excretion of sodium 0.54 (0.05–1.26) 0.8 (0.06–5.48) –
    All  values  are  medians  (range).  
  *     P   < 0.05 and †  P   < 0.01 versus admission.   
    ‡     Serum urine: creatinine ratio non-SI units.   145 HYPONATREMIA IN SEVERE MALARIA
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